Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort
about
The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-AnalysisFrom pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany.HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data.Cost of human immunodeficiency virus infection in Italy, 2007-2009: effective and expensive, are the new drugs worthwhile?HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy.Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines.The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment - results from an observational study in Germany.Generic substitution of antiretrovirals: patients' and health care providers' opinions.Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen.A Regional Drug and Therapeutics Committee-led Intervention to Reduce the Hospital Costs of Expensive HIV Drugs.Antiretroviral treatment-based cost saving interventions may offset expenses for new patients and earlier treatment start.
P2860
Q26865049-103E2FF8-FDAE-4BC0-9282-BAD3964427F5Q30925594-D14B37A5-0E1C-40D1-9153-1D31EE1F8711Q34474070-B2D98FEF-FED9-4C15-8BC5-150066F86196Q36226270-E888196D-214A-4F3E-85D5-1602F43E87CAQ36234850-F32214EE-D0B6-40D1-83AB-16F64795CFA0Q37077894-F08C3091-1D4D-4688-A253-409E4D05DD49Q37547161-BE881AA3-D22E-4072-95E8-F9D874EFF414Q38717415-6C62C96F-32B9-4C97-BDA3-9A8853F24E00Q40513800-32796CF8-1AFB-4E09-A23B-A93F95FA02C2Q40743211-D8F08D5C-BBC5-4D4E-A11B-0AB13E05FF2BQ42229844-0CC2282C-C03E-4884-9DCB-DECF450D5987
P2860
Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@ast
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@en
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@nl
type
label
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@ast
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@en
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@nl
prefLabel
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@ast
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@en
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@nl
P2093
P2860
P50
P3181
P1433
P1476
Calculation of direct antiretr ...... the German HIV ClinSurv cohort
@en
P2093
Andreas Plettenberg
Barbara Bartmeyer
Carlos Fritzsche
Christian Kollan
Frank Bergmann
Gerd Faetkenheuer
Hans-Jürgen Stellbrink
Heinz-August Horst
Johannes Bogner
Kirsten Hoeper
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0023946
P407
P577
2011-01-01T00:00:00Z